Obesity and Mortality in COVID-19: Cause or Association?
作者信息
Anand Abhinav, Kumar Ramesh
机构信息
Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi, India.
Department of Gastroenterology, All India Institute of Medical sciences, Patna, Bihar, India.
出版信息
Gastroenterology. 2023 Jun;164(7):1351-1352. doi: 10.1053/j.gastro.2020.08.055. Epub 2020 Sep 16.
Abstract
摘要
相似文献
1
Obesity and Mortality in COVID-19: Cause or Association?新冠疫情中的肥胖与死亡率：成因还是关联？
Gastroenterology. 2023 Jun;164(7):1351-1352. doi: 10.1053/j.gastro.2020.08.055. Epub 2020 Sep 16.
2
Association of body mass index with COVID-19 related in-hospital death.体重指数与新型冠状病毒肺炎相关院内死亡的关联
Clin Nutr. 2022 Dec;41(12):3137. doi: 10.1016/j.clnu.2022.03.010. Epub 2022 Mar 25.
3
Excess body weight is an independent risk factor for severe forms of COVID-19.超重是 COVID-19 严重症状的一个独立危险因素。
Metabolism. 2021 Apr;117:154703. doi: 10.1016/j.metabol.2021.154703. Epub 2021 Jan 6.
4
Obesity and Viral Infections.肥胖与病毒感染。
Gastroenterol Clin North Am. 2023 Jun;52(2):393-402. doi: 10.1016/j.gtc.2023.03.012.
5
Association of weight changes with SARS-CoV-2 infection and severe COVID-19 outcomes: A nationwide retrospective cohort study.体重变化与 SARS-CoV-2 感染和严重 COVID-19 结局的关联：一项全国性回顾性队列研究。
J Infect Public Health. 2023 Dec;16(12):1918-1924. doi: 10.1016/j.jiph.2023.10.002. Epub 2023 Oct 5.
6
Association between obesity and clinical prognosis in patients infected with SARS-CoV-2.肥胖与 SARS-CoV-2 感染患者临床预后的关系。
Infect Dis Poverty. 2020 Jun 29;9(1):80. doi: 10.1186/s40249-020-00703-5.
7
Sarcopenic obesity is the real problem in COVID-19 !肌少性肥胖是新冠肺炎中的真正问题！
Eur J Intern Med. 2021 Nov;93:103-104. doi: 10.1016/j.ejim.2021.08.007. Epub 2021 Aug 16.
8
Association between body-mass index, patient characteristics, and obesity-related comorbidities among COVID-19 patients: A prospective cohort study.新型冠状病毒肺炎患者的体重指数、患者特征与肥胖相关合并症之间的关联：一项前瞻性队列研究。
Obes Res Clin Pract. 2023 Jan-Feb;17(1):47-57. doi: 10.1016/j.orcp.2022.12.003. Epub 2022 Dec 20.
9
The J-shaped relationship between body mass index and mortality in patients with COVID-19: A dose-response meta-analysis.新冠病毒肺炎患者体重指数与死亡率之间的J形关系：一项剂量反应荟萃分析。
Diabetes Obes Metab. 2021 Jul;23(7):1701-1709. doi: 10.1111/dom.14382. Epub 2021 Apr 14.
10
Association of body mass index with long-term outcomes in older adults hospitalized for COVID-19: an observational study.体重指数与 COVID-19 住院老年患者长期结局的关联：一项观察性研究。
Sci Rep. 2024 Mar 29;14(1):7512. doi: 10.1038/s41598-024-58388-x.
引用本文的文献
1
Decline of onset-to-diagnosis interval and its impacts on clinical outcome of COVID-19 in China: a nation-wide observational study.中国 COVID-19 的发病至诊断间隔时间下降及其对临床结局的影响：一项全国性观察研究。
BMC Infect Dis. 2022 Aug 5;22(1):674. doi: 10.1186/s12879-022-07660-4.
本文引用的文献
1
Impact of Obesity on Outcomes of Patients With Coronavirus Disease 2019 in the United States: A Multicenter Electronic Health Records Network Study.肥胖对美国2019冠状病毒病患者预后的影响：一项多中心电子健康记录网络研究
Gastroenterology. 2020 Dec;159(6):2221-2225.e6. doi: 10.1053/j.gastro.2020.08.028. Epub 2020 Aug 21.
2
Factors associated with COVID-19-related death using OpenSAFELY.使用 OpenSAFELY 分析与 COVID-19 相关死亡的因素。
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.
3
Risk Factors for Mortality in Patients with COVID-19 in New York City.纽约市 COVID-19 患者死亡的风险因素。
J Gen Intern Med. 2021 Jan;36(1):17-26. doi: 10.1007/s11606-020-05983-z. Epub 2020 Jun 30.
4
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.武汉成人 COVID-19 住院患者严重程度和死亡率的危险因素。
J Allergy Clin Immunol. 2020 Jul;146(1):110-118. doi: 10.1016/j.jaci.2020.04.006. Epub 2020 Apr 12.
5
Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study.新型冠状病毒肺炎患者的非酒精性脂肪性肝病：一项回顾性研究。
J Hepatol. 2020 Aug;73(2):451-453. doi: 10.1016/j.jhep.2020.03.044. Epub 2020 Apr 8.
6
Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of Cancer.肥胖、非酒精性脂肪性肝病与脂肪细胞因子网络在癌症促进中的作用
Int J Biol Sci. 2019 Jan 1;15(3):610-616. doi: 10.7150/ijbs.29599. eCollection 2019.
7
High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.2型糖尿病且血浆转氨酶水平正常患者中非酒精性脂肪性肝病的高患病率
J Clin Endocrinol Metab. 2015 Jun;100(6):2231-8. doi: 10.1210/jc.2015-1966. Epub 2015 Apr 17.
Zotero 插件